Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)

Abstract Background Adolescent-onset psychosis is associated with more severe symptoms and poorer outcomes than adult-onset psychosis. The National Institute for Clinical Excellence (NICE) recommend that adolescents with first episode psychosis (FEP) should be offered a combination of antipsychotic...

Full description

Bibliographic Details
Main Authors: Melissa Pyle, Matthew R. Broome, Emmeline Joyce, Graeme MacLennan, John Norrie, Daniel Freeman, David Fowler, Peter M. Haddad, David Shiers, Chris Hollis, Jo Smith, Ashley Liew, Rory E. Byrne, Paul French, Sarah Peters, Jemma Hudson, Linda Davies, Richard Emsley, Alison Yung, Max Birchwood, Eleanor Longden, Anthony P. Morrison
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Trials
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13063-019-3506-1
id doaj-9d96b2895d2f4f1b9adf5bb69843ceb7
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Melissa Pyle
Matthew R. Broome
Emmeline Joyce
Graeme MacLennan
John Norrie
Daniel Freeman
David Fowler
Peter M. Haddad
David Shiers
Chris Hollis
Jo Smith
Ashley Liew
Rory E. Byrne
Paul French
Sarah Peters
Jemma Hudson
Linda Davies
Richard Emsley
Alison Yung
Max Birchwood
Eleanor Longden
Anthony P. Morrison
spellingShingle Melissa Pyle
Matthew R. Broome
Emmeline Joyce
Graeme MacLennan
John Norrie
Daniel Freeman
David Fowler
Peter M. Haddad
David Shiers
Chris Hollis
Jo Smith
Ashley Liew
Rory E. Byrne
Paul French
Sarah Peters
Jemma Hudson
Linda Davies
Richard Emsley
Alison Yung
Max Birchwood
Eleanor Longden
Anthony P. Morrison
Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)
Trials
First-episode psychosis
Cognitive behavioural therapy
Family intervention
Psychological intervention
Antipsychotic medication
Adolescent psychosis
author_facet Melissa Pyle
Matthew R. Broome
Emmeline Joyce
Graeme MacLennan
John Norrie
Daniel Freeman
David Fowler
Peter M. Haddad
David Shiers
Chris Hollis
Jo Smith
Ashley Liew
Rory E. Byrne
Paul French
Sarah Peters
Jemma Hudson
Linda Davies
Richard Emsley
Alison Yung
Max Birchwood
Eleanor Longden
Anthony P. Morrison
author_sort Melissa Pyle
title Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)
title_short Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)
title_full Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)
title_fullStr Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)
title_full_unstemmed Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)
title_sort study protocol for a randomised controlled trial of cbt vs antipsychotics vs both in 14–18-year-olds: managing adolescent first episode psychosis: a feasibility study (maps)
publisher BMC
series Trials
issn 1745-6215
publishDate 2019-07-01
description Abstract Background Adolescent-onset psychosis is associated with more severe symptoms and poorer outcomes than adult-onset psychosis. The National Institute for Clinical Excellence (NICE) recommend that adolescents with first episode psychosis (FEP) should be offered a combination of antipsychotic medication (APs), cognitive behavioural therapy (CBT) and family intervention (FI). The evidence for APs in treating psychosis is limited in adolescents compared to adults. Nevertheless, it indicates that APs can reduce overall symptoms in adolescents but may cause more severe side effects, including cardiovascular and metabolic effects, than in adults. CBT and FI can improve outcomes in adults, but there are no studies of psychological interventions (PI) in patients under 18 years old. Given this limited evidence base, NICE made a specific research recommendation for determining the clinical and cost effectiveness of APs versus PI versus both treatments for adolescent FEP. Methods/design The current study aimed to establish the feasibility and acceptability of conducting such a trial by recruiting 14–18-year-olds with a first episode of psychosis into a feasibility prospective randomised open blinded evaluation (PROBE) design, three-arm, randomised controlled trial of APs alone versus PI alone versus a combination of both treatments. We aimed to recruit 90 participants from Early Intervention and Child and Adolescent Mental Health Teams in seven UK sites. APs were prescribed by participants’ usual psychiatrists. PI comprised standardised cognitive behavioural therapy and family intervention sessions. Discussion This is the first study to compare APs to PI in an adolescent population with FEP. Recruitment finished on 31 October 2018. The study faced difficulties with recruitment across most sites due to factors including clinician and service-user treatment preferences. Trial registration Current controlled trial with ISRCTN, ISRCTN80567433. Registered on 27 February 2017.
topic First-episode psychosis
Cognitive behavioural therapy
Family intervention
Psychological intervention
Antipsychotic medication
Adolescent psychosis
url http://link.springer.com/article/10.1186/s13063-019-3506-1
work_keys_str_mv AT melissapyle studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT matthewrbroome studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT emmelinejoyce studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT graememaclennan studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT johnnorrie studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT danielfreeman studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT davidfowler studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT petermhaddad studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT davidshiers studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT chrishollis studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT josmith studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT ashleyliew studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT roryebyrne studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT paulfrench studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT sarahpeters studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT jemmahudson studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT lindadavies studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT richardemsley studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT alisonyung studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT maxbirchwood studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT eleanorlongden studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
AT anthonypmorrison studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps
_version_ 1724670782423957504
spelling doaj-9d96b2895d2f4f1b9adf5bb69843ceb72020-11-25T03:07:24ZengBMCTrials1745-62152019-07-0120111310.1186/s13063-019-3506-1Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)Melissa Pyle0Matthew R. Broome1Emmeline Joyce2Graeme MacLennan3John Norrie4Daniel Freeman5David Fowler6Peter M. Haddad7David Shiers8Chris Hollis9Jo Smith10Ashley Liew11Rory E. Byrne12Paul French13Sarah Peters14Jemma Hudson15Linda Davies16Richard Emsley17Alison Yung18Max Birchwood19Eleanor Longden20Anthony P. Morrison21The Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustInstitute for Mental Health, School of Psychology, University of BirminghamThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustCentre for Healthcare Randomised Trials, Health Services Research Unit, University of AberdeenEdinburgh Clinical Trials Unit, Centre for Population Health Sciences, Usher Institute, Nine Edinburgh BioQuarterDepartment of Psychiatry, Medical Sciences Division, University of Oxford, Warneford HospitalSchool of Psychology, Pevensey Building, University of SussexThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustNIHR MindTech MedTech Co-operative, Division of Psychiatry and Applied Psychology, Institute of Mental Health, University of NottinghamSchool of Allied Health and Community, Bredon Building, University of WorcesterInstitute for Mental Health, School of Psychology, University of BirminghamThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustDivision of Psychology and Mental Health, University of ManchesterCentre for Healthcare Randomised Trials, Health Services Research Unit, University of AberdeenDivision of Population Health, Health Services Research & Primary Care, University of ManchesterDepartment of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King’s College LondonThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustWarwick Medical School-Mental Health and Wellbeing, University of WarwickThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustAbstract Background Adolescent-onset psychosis is associated with more severe symptoms and poorer outcomes than adult-onset psychosis. The National Institute for Clinical Excellence (NICE) recommend that adolescents with first episode psychosis (FEP) should be offered a combination of antipsychotic medication (APs), cognitive behavioural therapy (CBT) and family intervention (FI). The evidence for APs in treating psychosis is limited in adolescents compared to adults. Nevertheless, it indicates that APs can reduce overall symptoms in adolescents but may cause more severe side effects, including cardiovascular and metabolic effects, than in adults. CBT and FI can improve outcomes in adults, but there are no studies of psychological interventions (PI) in patients under 18 years old. Given this limited evidence base, NICE made a specific research recommendation for determining the clinical and cost effectiveness of APs versus PI versus both treatments for adolescent FEP. Methods/design The current study aimed to establish the feasibility and acceptability of conducting such a trial by recruiting 14–18-year-olds with a first episode of psychosis into a feasibility prospective randomised open blinded evaluation (PROBE) design, three-arm, randomised controlled trial of APs alone versus PI alone versus a combination of both treatments. We aimed to recruit 90 participants from Early Intervention and Child and Adolescent Mental Health Teams in seven UK sites. APs were prescribed by participants’ usual psychiatrists. PI comprised standardised cognitive behavioural therapy and family intervention sessions. Discussion This is the first study to compare APs to PI in an adolescent population with FEP. Recruitment finished on 31 October 2018. The study faced difficulties with recruitment across most sites due to factors including clinician and service-user treatment preferences. Trial registration Current controlled trial with ISRCTN, ISRCTN80567433. Registered on 27 February 2017.http://link.springer.com/article/10.1186/s13063-019-3506-1First-episode psychosisCognitive behavioural therapyFamily interventionPsychological interventionAntipsychotic medicationAdolescent psychosis